Our patents

Thioredoxin Systems AB has a broad patent protection covering both composition of matter and medical use/treatment. Our patent strategy is global, and protected markets are considered clinically and commercially relevant for our products.

Granted or pending patents marked dark blue.

Patent family Patent/application no. Granted patents Pending patents Expiry
Composition comprising selenazol or thiazolone derivates and metal ions and method of treatment therewith US 10,058,542
US 11,013,730
US 2036
Method of treatment of Helicobacter Pylori infection using PZ25 (ebsulfur) US 8,592,468 US 2027
Antibiotic compositions comprising silver and selenium WO 2018/104777 US Australia, Brazil, Canada, Europe, Japan, South Korea 2037